Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin Regimen

Preferred Label : Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin Regimen;

NCIt synonyms : BCAP; BLEO/CDDP/CTX/DOX; Bleomycin Cisplatin Cyclophosphamide Doxorubicin; Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin; Bleomycin-Cisplatin-Cyclophosphamide-Doxorubicin;

NCIt related terms : PAB-Esc-C;

NCIt definition : A regimen consisting of bleomycin, cisplatin, cyclophosphamide and doxorubicin that can be used for the treatment of ovarian cancer.;

Détails

Origin ID

C9626;

UMLS CUI

C1510468;

C0069923;

Automatic exact mappings (from CISMeF team)
- Phosphoinositide 3-kinase adaptor protein 1 [OMIM gene]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
UMLS correspondences (same concept)
- BCAP protocol [MeSH concept]
- PAB-CAP protocol [MeSH concept]
- PAB-CAP protocol [MeSH Supplementary Concept]
chemotherapy_regimen_has_component
- Bleomycin Sulfate [NCIt concept]
- Cisplatin [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients